Eliminate forum guesswork and reconstitution math errors. Peer-reviewed human equivalent dosing (HED), oncology and cardiac contraindication filters, and sterile volumetric calibration.
Synergistic focal adhesion kinase (FAK) activation and G-actin sequestering via BPC-157 and Thymosin Ξ²4. Up-regulates local VEGFR2 angiogenesis while accelerating fibroblast migration without systemic growth hormone elevation.
6 to 8 weeks on active cycle, followed by a mandatory 4-week receptor sensitivity washout period to avoid desensitization.
Screen for active neoplasm or proliferative retinopathy prior to initiation (angiogenic VEGF caution).
Designed from the ground up to replace chaotic forum threads and bro-science speculation with clinical decision support tools.
5-step personalized intake questionnaire that stratifies risk by biological sex, prior exposure, oncology contraindications, and cardiac baseline. Computes human equivalent dosage (HED) and schedules receptor washout intervals.
Eliminate dangerous 10x microgram-to-unit math errors. An interactive SVG syringe models 30u, 50u, and 100u barrels with real-time liquid meniscus rendering, tick graduation warnings, and instant shareable URL hydration.
Don't hunt across multiple medical supply sites. Access turnkey all-in-one preparation kits (Hospira BAC water, BD LDS needles, PES filters) and Quest/LabCorp baseline blood panels.
Ask questions about the evidence, bring a clear summary to your clinician, and put your schedule in the calendar you already use.
Start with the research library, check a calculation, or ask Helia a question.
Try the monthly plan free for 90 days. Explore the research and see how the tools fit into your routine.
The free tools include a printable summary. You can also unlock calendar downloads with an email.
Comparative overview of established therapeutic peptide combinations, literature-backed human equivalent dosing, and mandatory receptor washout schedules.
| Archetype | Primary Target | Key Active Compounds | Standard HED Range | Receptor Washout | Actions |
|---|---|---|---|---|---|
|
π©Ή Tissue & Joint Repair
|
Tendon, ligament & cartilage healing | BPC-157 + TB-500 | 250-500mcg / 2-2.5mg | 6β8 wks ON / 4 wks OFF | |
|
πΏ Gut & Mucosal Healing
|
Leaky gut, intestinal permeability, IBD | BPC-157 Arginate + KPV | 500mcg Oral / 200-400mcg | 8β12 wks continuous | |
|
β‘ Metabolism & Weight Loss
|
Visceral adiposity & insulin sensitivity | Tirzepatide + MOTS-c | 2.5-15mg wk / 5mg 3x/wk | 16 wks / titration | |
|
π Mitochondrial Longevity
|
Cardiolipin restoration & telomerase | SS-31 + Epithalon | 2-5mg daily / 5-10mg | 10β20 days pulsed / yr | |
|
π Growth Hormone & Sleep
|
Slow-wave delta sleep & somatopause | CJC-1295 + Ipamorelin | 100mcg / 200-300mcg | 5 days ON / 2 days OFF | |
|
π§ Cognition & Neuro-Repair
|
Hippocampal BDNF, NGF & focus | Semax + Selank | 250-500mcg nasal daily | 4β6 wks ON / 2 wks OFF |
Why clinicians, researchers, and harm-reduction advocates rely on Helia Protocols over crowdsourced forum speculation.
Animal study data cannot be directly copied to humans. Helia automatically normalizes animal dosages by body surface area (BSA) using FDA conversion factors:
Eliminates the catastrophic 10x reconstitution error by mathematically calculating syringe barrel volume, tick graduation tolerances, and dead space retention.
No growth factor or secretagogue protocol should be initiated blind. We index necessary Quest/LabCorp baseline panels (IGF-1, PSA, CMP, hs-CRP, HbA1c) prior to administration.
We do not sell unapproved grey-market chemical powders. We provide validated protocol architecture software, sterile medical compounding hardware, and licensed clinical physician routing.
Have specific questions regarding receptor binding affinities, peptide reconstitution dilution, half-lives, or published human trial outcomes? Click any prompt below to query our clinical literature engine:
Peer-reviewed literature syntheses answering high-frequency patient questions.
Comprehensive clinical dosing guide, reconstitution math, synergistic mechanisms, and safety guardrails for accelerated tendon and ligament recovery.
Oral arginate salt stabilization, occludin tight-junction restoration, NF-ΞΊB inhibition, and clinical protocol dosing for Crohn's and IBD.
Dual & triple incretin agonism, microdosing titration schedules, and lean-mass preservation protocols.
Pituitary secretagogue synergy, slow-wave sleep delta amplitude, 5-on/2-off cycling, and IGF-1 monitoring.
Hippocampal BDNF/TrkB stimulation, GABAergic modulation, executive focus, and intranasal bioavailability.
Step-by-step sterile reconstitution manual: bacteriostatic water volume, syringe tick calibration, and cold-chain storage.